Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study - Denys, P; Del Popolo, G; Amarenco, G (Neurourol Urodyn, 2017)
: